Search clinical trials for: SHC014748M

Total 5 results

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Follicular Lymphoma(FL) | Marginal Zone Lymphoma(MZL)

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

A Food-Effect Study of SHC014748M in Healthy Subjects

Healthy Volunteer

China
Seoul National University Bundang Hospital

Completed

Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty

Avascular Necrosis of Hip | Total Hip Replacement Arthroplasty

Korea, Republic of

3

Subscribe